JENNIFER MAZORRA: Open Payments
NPI 1629323407 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 17 payments from 11 companies in 2025. Trend: 2023 $66 · 2024 $124 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $89 |
| Novo Nordisk Inc | 2 | $40 |
| PFIZER INC. | 2 | $39 |
| Cleerly, Inc. | 1 | $34 |
| Esperion Therapeutics, Inc. | 1 | $28 |
| BridgeBio Pharma, Inc. | 1 | $24 |
| SCPHARMACEUTICALS INC. | 1 | $21 |
| Terumo Medical Corporation | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: Repatha, Wegovy, ELIQUIS, Cleerly Ischemia, NEXLETOL, Attruby, FUROSCIX, TR BAND.
Industry payments across FL — which companies pay providers there.
